These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32166175)

  • 1. Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?
    Brühl AB; d'Angelo C; Sahakian BJ
    Brain Neurosci Adv; 2019; 3():2398212818816018. PubMed ID: 32166175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.
    Sahakian BJ; Bruhl AB; Cook J; Killikelly C; Savulich G; Piercy T; Hafizi S; Perez J; Fernandez-Egea E; Suckling J; Jones PB
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1677):20140214. PubMed ID: 26240429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
    Sahakian BJ; Morein-Zamir S
    Lancet Psychiatry; 2015 Apr; 2(4):357-62. PubMed ID: 26360089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species.
    Cope ZA; Minassian A; Kreitner D; MacQueen DA; Milienne-Petiot M; Geyer MA; Perry W; Young JW
    Neuropharmacology; 2017 Oct; 125():254-262. PubMed ID: 28774856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive enhancing effects of modafinil in healthy volunteers.
    Turner DC; Robbins TW; Clark L; Aron AR; Dowson J; Sahakian BJ
    Psychopharmacology (Berl); 2003 Jan; 165(3):260-9. PubMed ID: 12417966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
    Schifano F; Catalani V; Sharif S; Napoletano F; Corkery JM; Arillotta D; Fergus S; Vento A; Guirguis A
    Drugs; 2022 Apr; 82(6):633-647. PubMed ID: 35366192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroethical issues in cognitive enhancement.
    Sahakian BJ; Morein-Zamir S
    J Psychopharmacol; 2011 Feb; 25(2):197-204. PubMed ID: 20212064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs, games, and devices for enhancing cognition: implications for work and society.
    Brühl AB; Sahakian BJ
    Ann N Y Acad Sci; 2016 Apr; 1369(1):195-217. PubMed ID: 27043232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroethical issues in pharmacological cognitive enhancement.
    Mohamed AD
    Wiley Interdiscip Rev Cogn Sci; 2014 Sep; 5(5):533-549. PubMed ID: 26308743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
    Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Liechti ME; Borgwardt S
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):712-720. PubMed ID: 28525569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
    Repantis D; Schlattmann P; Laisney O; Heuser I
    Pharmacol Res; 2010 Sep; 62(3):187-206. PubMed ID: 20416377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.
    d'Angelo LC; Savulich G; Sahakian BJ
    Br J Pharmacol; 2017 Oct; 174(19):3257-3267. PubMed ID: 28427114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges.
    Ricci G
    Front Psychiatry; 2020; 11():53. PubMed ID: 32127792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of modafinil on cognitive and meta-cognitive performance.
    Baranski JV; Pigeau R; Dinich P; Jacobs I
    Hum Psychopharmacol; 2004 Jul; 19(5):323-32. PubMed ID: 15252824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain.
    Urban KR; Gao WJ
    Front Syst Neurosci; 2014; 8():38. PubMed ID: 24860437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.
    Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Egloff L; Liechti ME; Borgwardt S
    Int J Neuropsychopharmacol; 2018 Apr; 21(4):345-354. PubMed ID: 29206921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial.
    Nuijten M; Blanken P; Van den Brink W; Goudriaan AE; Hendriks VM
    J Psychopharmacol; 2016 Jul; 30(7):616-26. PubMed ID: 27147591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.